fda warning letters compounded semaglutide telehealth 2024 2025 I'm calling on Meta to enforce its own policies and remove these irresponsible, misleading and, at times, dangerous advertisements for GLP-1 weight loss drugs from its social media platforms: https://tinyurl.com/2u83nhsw FDA issued 25 warning letters

doi: 10.3389/fphar.2025.1709259 Received 19 September 2025 Revised 27 October 2025 Accepted 29 October 2025 Published 18 December 2025 Volume 16 - 2025 Edited by Vanessa Souza-Mello, Rio de Janeiro State University, Brazil Reviewed by Eduardo Duarte-Silva, University of Texas Health Science Center at Houston, United States Updates Copyright 2025 Cheng and Kim

Independent editorial content

They looked at nearly a half million people taking a GLP-1 for their diabetes and compared them to a similar group of 1.6 million people taking other medications

Kanwal F, Shubrook JH, Adams LA, Pfotenhauer K, Wong VW, Wright E, et al